Literature DB >> 17169797

Granulocytic sarcoma: 32 cases and review of the literature.

Semra Paydas1, Suzan Zorludemir, Melek Ergin.   

Abstract

Thirty-two cases of granulocytic sarcoma (GS) are reported in this paper. Age range was from 16 - 70 years. GS was accompanied by AML in 13 cases, ALL (My+) in one case, CML in 11 cases and MDS in two cases. GS was diagnosed simultaneously with leukemia in five cases and preceded the leukemia in eight. Lymph node and soft tissue were the most commonly detected localizations. Seven cases had first been diagnosed as NHL. Histopathologically blastic, immature and mature variants were found in 11, nine and 11 cases respectively and overall survival was shortest in the blastic type. Myeloperoxidase and lysozyme were found to be positive in 30 and 24 cases respectively. Therapy was radiation in five cases and surgery in three. Systemic chemotherapy was given to the cases. The clinical outcome of the patients after the diagnosis of GS was poor. GS is a unique entity; prognosis is poor but it is important to detect the signaling pathways associated with migration of myeloid cells to the extra-medullary tissues. The critical factors for detecting this interesting tumor are to be aware of this disease, cooperation between clinician and pathologist and the application of special stains to detect the myeloid origin.

Entities:  

Mesh:

Year:  2006        PMID: 17169797     DOI: 10.1080/10428190600967196

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  88 in total

1.  Isolated pancreatic granulocytic sarcoma: a case report and review of the literature.

Authors:  Xin-Ping Li; Wen-Fang Liu; Shu-Rong Ji; She-Hua Wu; Jian-Jun Sun; Yue-Zu Fan
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Granulocytic sarcoma of the breast: A case report.

Authors:  Xiao-E Huang; Yu-Jie Li; Xiao-Dong Zhou
Journal:  Oncol Lett       Date:  2015-07-24       Impact factor: 2.967

3.  Myeloid sarcoma causing airway obstruction.

Authors:  Aaron R Belknap; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

4.  [Unilateral swelling of the lacrimal gland in a 15-year-old female patient].

Authors:  A I Berta; N Naumann-Bartsch; A Agaimy; M Metzler; F E Kruse; L Holbach
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

5.  Myeloid sarcoma of the nasopharynx mimicking an aggressive lymphoma.

Authors:  Jacques Raphael; Alexander Valent; Colette Hanna; Nathalie Auger; Odile Casiraghi; Vincent Ribrag; Stephane De Botton; Veronique Saada
Journal:  Head Neck Pathol       Date:  2013-10-08

6.  Refractory de novo myeloid sarcoma: a case report and therapeutic strategy based on bone marrow minimal residual disease.

Authors:  Daichi Inoue; Yuya Nagai; Takaharu Kimura; Sonoko Shimoji; Minako Mori; Katsuhiro Togami; Sumie Tabata; Masayuki Kurata; Akiko Matsushita; Kiminari Ito; Hisako Hashimoto; Hayato Maruoka; Eiko Yamashita; Kenichi Nagai; Yukihiro Imai; Hirohumi Shirane; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2009-06-10       Impact factor: 2.490

7.  Myeloid sarcoma as the presenting symptom of chronic myelogenous leukemia blast crisis.

Authors:  Rebecca A Levy; Mabel A Mardones; Micah M Burch; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-07

8.  Myeloid sarcoma in essential thrombocythemia that transformed into acute myeloid leukemia.

Authors:  Hisaharu Shikata; Takuya Matumoto; Hiroki Teraoka; Masahiko Kaneko; Mamoru Nakanishi; Tadashi Yoshino
Journal:  Int J Hematol       Date:  2009-01-27       Impact factor: 2.490

9.  Temporal bone myeloid sarcoma.

Authors:  Ki-Hong Chang; Dong-Kee Kim; Beom-Cho Jun; Yong-Soo Park
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

10.  Granulocytic sarcoma of the breast without development of bone marrow involvement: a case report.

Authors:  Teresa A Vela-Chávez; Myrna D Arrecillas-Zamora; L Yolanda Quintero-Cuadra; Falko Fend
Journal:  Diagn Pathol       Date:  2009-01-06       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.